𝔖 Bobbio Scriptorium
✦   LIBER   ✦

362 SERUM HEPATITIS B SURFACE ANTIGEN LEVEL IS ASSOCIATED WITH LIVER FIBROSIS IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B

✍ Scribed by P.-N. Cheng; H.-W. Tsai; T.-T. Chang

Book ID
117379507
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
88 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Correlation of serum hepatitis B surface
Correlation of serum hepatitis B surface antigen level with response to entecavir in naΓ―ve patients with chronic hepatitis B
✍ Myoung Hee Lee; Da Mi Lee; Soon Sun Kim; Jae Youn Cheong; Sung Won Cho πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAg‐positive and HBeAg

Peginterferon alpha-2b is safe and effec
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
✍ Erik H. C. J. Buster; Bettina E. Hansen; Maria Buti; Jean Delwaide; Claus Nieder πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

for the HBV 99-01 study group Chronic hepatitis B (CHB) patients with advanced fibrosis are often not considered for treatment with peginterferon (PEG-IFN) because IFN therapy may precipitate immunological flares, potentially inducing hepatic decompensation. We investigated the efficacy and safety o